Komori
Governance4539NIPPON CHEMIPHAR CO.,LTD.Pharmaceuticals

Corporate Governance Report 2026/06/17

The company is a company with an Audit & Supervisory Board, and its Board of Directors comprises 8 members, including 3 outside directors. The report does not indicate any changes from the previous report.

Worth reading
46Recurring
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
8
Directors (including 3 outside directors)
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit & Supervisory Board
Number of directors8 directors (including 3 outside directors)
Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit & Supervisory Board
Number of directors8 directors (including 3 outside directors)
Items this document does not state (6)
Number of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The objectives are to maintain and enhance corporate value and the common interests of shareholders, improve management efficiency, strengthen corporate governance, enhance management transparency, and ensure fair management.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/06/17 | NIPPON CHEMIPHAR CO.,LTD. (4539) timely disclosure | Komori